This indicates that the disturbed balance between the microbiota, immune cells, and epithelial cells results in the activation of the CCL4L2‐VSIR pathway, which plays a crucial role in protecting the intestinal mucosa in individuals with GSD‐Ib. Here, CCL4L2 is linked to glycogen storage disease Ib.